-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target

Benzinga·05/01/2025 18:20:21
Listen to the news
Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $2.25 price target.